Nora E Rosenberg1, Christopher D Pilcher, Michael P Busch, Myron S Cohen. 1. aDivision of Infectious Diseases, University of North Carolina, Chapel Hill, USA bUniversity of North Carolina Project, University of North Carolina, Lilongwe, Malawi cSchool of Medicine, University of California at San Francisco dBlood Systems Research Institute, San Francisco, California, USA.
Abstract
PURPOSE OF REVIEW: Detection of early HIV infections (EHIs), including acute HIV infection (AHI), is important for individual health, prevention of HIV transmission, and measurement of HIV incidence. We describe markers of EHI, diagnostic strategies for detecting these markers, and ways to incorporate these strategies into diagnostic and HIV incidence algorithms. RECENT FINDINGS: For individual diagnosis in the USA and Europe, laboratory-based diagnostic algorithms increasingly incorporate fourth-generation HIV antigen tests, allowing for earlier detection. In some sub-Saharan African settings, symptom-based screening is being explored to identify subsets of persons at high risk for AHI. Point-of-care diagnostics designed for AHI detection are in the pipeline and, if validated, represent an opportunity for real-time AHI diagnosis. At the population level, multiassay algorithms are promising new strategies for estimating HIV incidence on the basis of several assays applied to cross-sectional samples. These algorithms can be developed to optimize performance, in addition to cost and logistical considerations. SUMMARY: There are important recent advances in detection of EHIs at the individual and population levels. Applying optimal combinations of tests in diagnostic and HIV incidence algorithms is urgently needed to support the multiple goals derived from enhanced detection and discrimination of EHIs.
PURPOSE OF REVIEW: Detection of early HIV infections (EHIs), including acute HIV infection (AHI), is important for individual health, prevention of HIV transmission, and measurement of HIV incidence. We describe markers of EHI, diagnostic strategies for detecting these markers, and ways to incorporate these strategies into diagnostic and HIV incidence algorithms. RECENT FINDINGS: For individual diagnosis in the USA and Europe, laboratory-based diagnostic algorithms increasingly incorporate fourth-generation HIV antigen tests, allowing for earlier detection. In some sub-Saharan African settings, symptom-based screening is being explored to identify subsets of persons at high risk for AHI. Point-of-care diagnostics designed for AHI detection are in the pipeline and, if validated, represent an opportunity for real-time AHI diagnosis. At the population level, multiassay algorithms are promising new strategies for estimating HIV incidence on the basis of several assays applied to cross-sectional samples. These algorithms can be developed to optimize performance, in addition to cost and logistical considerations. SUMMARY: There are important recent advances in detection of EHIs at the individual and population levels. Applying optimal combinations of tests in diagnostic and HIV incidence algorithms is urgently needed to support the multiple goals derived from enhanced detection and discrimination of EHIs.
Authors: Oliver Laeyendecker; Ron Brookmeyer; Matthew M Cousins; Caroline E Mullis; Jacob Konikoff; Deborah Donnell; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Shruti H Mehta; Jacquie Astemborski; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Thomas C Quinn; Susan H Eshleman Journal: J Infect Dis Date: 2012-11-05 Impact factor: 5.226
Authors: Yen T Duong; Maofeng Qiu; Anindya K De; Keisha Jackson; Trudy Dobbs; Andrea A Kim; John N Nkengasong; Bharat S Parekh Journal: PLoS One Date: 2012-03-27 Impact factor: 3.240
Authors: Miriam Taegtmeyer; Peter MacPherson; Kathy Jones; Mark Hopkins; Jay Moorcroft; David G Lalloo; Anu Chawla Journal: PLoS One Date: 2011-11-22 Impact factor: 3.240
Authors: Marlous L Grijsen; Radjin Steingrover; Ferdinand W N M Wit; Suzanne Jurriaans; Annelies Verbon; Kees Brinkman; Marchina E van der Ende; Robin Soetekouw; Frank de Wolf; Joep M A Lange; Hanneke Schuitemaker; Jan M Prins Journal: PLoS Med Date: 2012-03-27 Impact factor: 11.069
Authors: Sarah Fidler; Kholoud Porter; Fiona Ewings; John Frater; Gita Ramjee; David Cooper; Helen Rees; Martin Fisher; Mauro Schechter; Pontiano Kaleebu; Giuseppe Tambussi; Sabine Kinloch; Jose M Miro; Anthony Kelleher; Myra McClure; Steve Kaye; Michelle Gabriel; Rodney Phillips; Jonathan Weber; Abdel Babiker Journal: N Engl J Med Date: 2013-01-17 Impact factor: 91.245
Authors: Oliver Laeyendecker; Michal Kulich; Deborah Donnell; Arnošt Komárek; Marek Omelka; Caroline E Mullis; Greg Szekeres; Estelle Piwowar-Manning; Agnes Fiamma; Ronald H Gray; Tom Lutalo; Charles S Morrison; Robert A Salata; Tsungai Chipato; Connie Celum; Erin M Kahle; Taha E Taha; Newton I Kumwenda; Quarraisha Abdool Karim; Vivek Naranbhai; Jairam R Lingappa; Michael D Sweat; Thomas Coates; Susan H Eshleman Journal: PLoS One Date: 2013-11-13 Impact factor: 3.240
Authors: Brettania L W Lopes; Joseph J Eron; Michael J Mugavero; William C Miller; Sonia Napravnik Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Ann M Dennis; Shuntai Zhou; Christopher J Sellers; Emily Learner; Marc Potempa; Myron S Cohen; William C Miller; Joseph J Eron; Ronald Swanstrom Journal: J Infect Dis Date: 2018-10-20 Impact factor: 5.226
Authors: JoAnn D Kuruc; Anna B Cope; Lynne A Sampson; Cynthia L Gay; Rhonda M Ashby; Evelyn M Foust; Myra Brinson; John E Barnhart; David Margolis; William C Miller; Peter A Leone; Joseph J Eron Journal: J Acquir Immune Defic Syndr Date: 2016-01-01 Impact factor: 3.731
Authors: Susan H Eshleman; Estelle Piwowar-Manning; Mariya V Sivay; Barbara Debevec; Stephanie Veater; Laura McKinstry; Linda-Gail Bekker; Sharon Mannheimer; Robert M Grant; Margaret A Chesney; Thomas J Coates; Beryl A Koblin; Jessica M Fogel Journal: J Clin Virol Date: 2018-01-11 Impact factor: 3.168
Authors: Eleanor R Gray; Robert Bain; Olivia Varsaneux; Rosanna W Peeling; Molly M Stevens; Rachel A McKendry Journal: AIDS Date: 2018-09-24 Impact factor: 4.177